It's time to phase in<i><scp>RHD</scp></i>genotyping for patients with a serologic weak<scp>D</scp>phenotypeS. Gerald Sandler, Clayton D. Simon, Willy A. Flegel et al.|Transfusion|2014Cited by 195
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetingsJill R. Storry, Vered Yahalom, Qing Chen et al.|Vox Sanguinis|2018Cited by 99
It's time to phase out “serologic weak D phenotype” and resolve D types with <i>RHD</i> genotyping including weak D type 4Willy A. Flegel, S. Gerald Sandler, Gregory A. Denomme et al.|Transfusion|2020Cited by 56
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systemsChristoph Gassner, Catherine A. Hyland, Lilian Castilho et al.|Vox Sanguinis|2022Cited by 30
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015.Willy A. Flegel, Gregory A. Denomme, Margaret Keller et al.|PubMed|2014Cited by 14